Chloride ion

Generic Name: Chloride ion

Drug Type: Small Molecule

Chemical Formula: Cl

CAS Number: 16887-00-6

Unique Ingredient Identifier: Q32ZN48698

Clinical Trials

Mechanism of Cardiac and Cerebral Function Injury Caused by Intraoperative Limb Ischemia-reperfusion

Not Applicable

Recruiting

Conditions: Ischemic Reperfusion Injury

Interventions: Drug: 0.9% Sodium chloride
Device: Tourniquet(Early)
Device: Tourniquet(Late)
Drug: Dexmedetomidine

First Posted Date: 2022-12-22

Last Posted Date: 2022-12-22

Lead Sponsor: Hebei Medical University Third Hospital

Target Recruit Count: 120

Registration Number: NCT05661227

Locations: 🇨🇳
The Third Hospital of Hebei Medical University, Shijiazhuang City, Hebei, China

Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean Section

Phase 1

Recruiting

Conditions: Postoperative Ileus

Interventions: Drug: 0.9%sodium chloride
Drug: Dexamethasone

First Posted Date: 2022-12-16

Last Posted Date: 2024-12-02

Lead Sponsor: Assiut University

Target Recruit Count: 90

Registration Number: NCT05654649

Locations: 🇪🇬
woman health hospital , Assiut university, Assiut, Egypt

Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

Phase 1

Recruiting

Conditions: Cardiac Arrest

Interventions: Drug: Landiolol
Drug: Sodium Chloride (NaCl) 0.9%

First Posted Date: 2022-09-26

Last Posted Date: 2023-03-17

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 32

Registration Number: NCT05554978

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait

Not Applicable

Conditions: Block
Spastic Hemiplegia
Gait, Hemiplegic
Neurologic Disorder

Interventions: Drug: Sodium Chloride Injection
Drug: Ropivacaine injection

First Posted Date: 2022-08-29

Last Posted Date: 2022-08-29

Lead Sponsor: Henri Mondor University Hospital

Target Recruit Count: 30

Registration Number: NCT05519592

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

Phase 1

Completed

Conditions: Healthy Volunteers
Renal Impairment

Interventions: Drug: pudexacianinium chloride

First Posted Date: 2022-08-10

Last Posted Date: 2024-12-04

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 28

Registration Number: NCT05495581

Locations: 🇺🇸
Advanced Pharma CR, LLC, Miami, Florida, United States
🇯🇵
Sekino Clinical Pharmacology Clinic, Toshima-ku, Tokyo, Japan
🇺🇸
Pinnacle Research Group, Anniston, Alabama, United States

and more 1 locations

Peroperative Administration of Tranexamic Acid in Roux-en-Y Gastric Bypass and One-anastomosis Gastric Bypass

Phase 3

Not yet recruiting

Conditions: Hemorrhage
Bleeding

Interventions: Drug: Tranexamic Acid Injection [Cyklokapron]
Drug: Sodium chloride 0.9%

First Posted Date: 2022-07-19

Last Posted Date: 2022-07-19

Lead Sponsor: Franciscus Gasthuis

Target Recruit Count: 1524

Registration Number: NCT05464394

A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery

Phase 2

Terminated

Conditions: Melanoma
Sentinel Lymph Node Biopsy
Breast Cancer

Interventions: Drug: pudexacianinium chloride

First Posted Date: 2022-07-14

Last Posted Date: 2024-11-20

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 1

Registration Number: NCT05457842

Locations: 🇺🇸
UCI Irvine Health-Chao Family Comprehensive Cancer Center Cancer, Orange, California, United States

Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults

Phase 1

Not yet recruiting

Conditions: Malaria

Interventions: Biological: Sodium chloride (NaCl) 0.9%
Drug: Pyronaridine Tetraphosphate, Artesunate Drug Combination
Biological: MVA ME-TRAP
Biological: PfSPZ Challenge (NF54)
Biological: ChAd63 ME-TRAP

First Posted Date: 2022-07-01

Last Posted Date: 2024-12-06

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 30

Registration Number: NCT05441410

A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

Not Applicable

Recruiting

Conditions: Injection
Non-cardiac Surgery
Delirium in Old Age
Post Operative Delirium

Interventions: Drug: Sodium Chloride Injection
Drug: Huperzine A Injection

First Posted Date: 2022-02-16

Last Posted Date: 2025-04-02

Lead Sponsor: Second Affiliated Hospital of Wenzhou Medical University

Target Recruit Count: 40

Registration Number: NCT05242419

Locations: 🇨🇳
The 2nd Second Affiliated Hospital of WMU Phase I Clinical Trial Unit /Center Of Bioequivalence Study, Wenzhou, Zhejiang, China

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Phase 2

Active, not recruiting

Conditions: COVID-19

Interventions: Drug: 0.9%sodium chloride
Drug: unfractionated heparin

First Posted Date: 2022-01-24

Last Posted Date: 2025-04-09

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 506

Registration Number: NCT05204550

Locations: 🇦🇺
The Northern Hospital, Epping, Victoria, Australia

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy